loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 212327 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 FEDRATINIB HYDROCHLORIDE (1)

filter

01 BRISTOL-MYERS (1)

filter

01 CAPSULE;ORAL (1)

filter

01 EQ 100MG BASE (1)

filter

01 USA (1)

URL Supplier Web Content
CAPSULE;ORAL
EQ 100MG BASE
INREBIC
USA
212327
2019-08-16
RX
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 212327

Looking for CTD TGA MCC DOSSIER APPLICATION 212327 1

19

Bristol Myers Squibb, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is FEDRATINIB HYDROCHLORIDE, with a corresponding application number 212327 and regulatory information .

proudly manufactured in the

approval since 2019-08-16

Bristol Myers Squibb's INREBIC CAPSULE;ORAL, medication with EQ 100MG BASE of FEDRATINIB HYDROCHLORIDE.

Post Enquiry
POST ENQUIRY